THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
https://doi.org/10.15789/1563-0625-2005-5-6-489-494
Abstract
In this review, the reasons for successful transplantation of stem cells have been shidied. Special attention has been paid to the influence of some stem cells types on thr immune system, mainly, on activated T-lymphocytes. It has been shown, that mesenchymal and stromal stem cells in vitro blocked the production of T-lymphocytes activated by allogenic cells or non-specific mitogens. Thus, contact with stem cells can impede the development of the graft immunity and inhibit the development of new T-lymphocyte clones. After the immunosuppressive therapy and stem transplantation of CD4+ population, as well as the impediment of the restoration of T-lymphocyte repertoire are observed. This effect is probably connected with immunomodulatory (similar to immunoregulatory) capacity of transferred allogenic or autologous stem cells. These studies have shown the risk of immunosuppression connected with the application of stem cells.
About the Authors
V. A. Lyashenko
ГУ НИИ Вирусных препаратов им. О.Г.Анджапаридзе РАМН, Москва
Russian Federation
Russian Federation
D. V. Goldshtein
Институт стволовой клетки и клеточных технологий РАМН, Москва
Russian Federation
Russian Federation
A. A. Rzhaninova
Институт стволовой клетки и клеточных технологий РАМН, Москва
Russian Federation
Russian Federation
References
1. Bartholomew A., Sturgeon C., Siatskas M., Terrer K., Mc Intosh K., Patil S., Hardy W., Devine S., Ucker D., Plane R., Mosely A., Hoffman R. Mesenshymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo // Experimental Hematology. — 2002. — Vol.30. — P.42–48.
2. Bellucci R., Ritz J. Allogenic stem cell transplantation for multiple myeloma // Rev Clin Exp Hematol. – 2002. — Vol. 6. — P.205–224.
3. Bomberger С., Singh–Jairam M., Rodey G., Guerriero A., Yeager A.M., Fleming W.H., Holl H.K., Waller E.K. Lymphoid reconstitution After Autologous PBSC Transplantation With FACS–Sorted CD34+ Hematopoietic Progenitors // Blood. — 1998. — Vol. 91. — P.2588–2600.
4. Damiani D., Stocchi R., Masolini P., Michelutti A., Sperito A., Geromin A., Skert C., Serno M., Micheieli M., Baccarani M., Fanin R. CD34+ selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection // Annals of Oncology. — 2003. — Vol.14. — P.475–480.
5. Deans R.J., Moseley A.B. Mesenchymal stem cells and gene therapy applications // Eur. Cytokine Networks. — 2000. — Vol.11. — P.323–324.
6. Di Nicola M., Carmello C., Magni M., Milanesi M., Longoni P.D., Mattenci P., Crisanti S., Gianni A.M. Human bone marrow stromal cell suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogen stimuli // Blood. — 2002. — Vol.99. — P.3838–3843.
7. Di Persio J.F., Kboury H., Haug J., Rass V.J., Adkins D.R., Goodnough L.T., Brown R.A. Innovations in Allogenic Stem–Cell Transplantation // Seminars in Hematology. — 2000. — Vol.37. ( Suppl. 2.). — P.33–41.
8. Djouad F., Plence P., Bony C., Tropel P., Appareilly F., Sani J., Noel D., Forgessen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals // Blood. — 2003. — Vol.102. — P.3837–3844.
9. Fandrich F., Lin X., Chai G.X., Schulze V., Ganten D., Bader M., Kalle J., Huang D.S., Pavaresch K., Zavarava N., Binas B. Preimplantation–stage stem cells induces long–term allogeneic graft acceptance without supplementary host conditioning // Nat.Med. — 2002. — Vol.8. — P.171–178.
10. Flowers M., Parker P., Johnston L., Matos A.V., Storer B., Bensinger W.I., Storb R., Appelbaum F.R., Forman S.I., Blume K.G., Martin P.J. Comparison of chronic graft versus host disease after transplantation of peripheral stem cells versus bone marrow in allogeneic recipients: long term follow up a randomized trial //Blood. — 2002. — Vol.100. — P.415–419.
11. Galy A., Rudraraju S., Baynes R., Klein R. Recovery of lymphocytes and dendritic cell subsets after autologous CD34+ cell transplantation // Bone Marrow Transplant 2000. — Vol. 25. — P.1249–1255.
12. Gotherstrom C., Ringden O., Tammic C., Zettenberg E., Westgren M., Le Blane K. Immunologic properties of human fetal mesenchymal stem cells // American Journal of Obstetrics and Gynecology. — 2004. Vol.190. — P.239–245.
13. Han Q., Deng W., Li C., Liao L., Ge W., Zhao Z., Roux E. Allogeneic adult stem cells establish long–term residence in recipient tissues and facilitate skin transplantation // Exp. Hematol. — 2003. — Vol.31. — P.158–163.
14. Heim J.A., Hanasono Y., Giri N., Wu T., Childs R., Sellers S.E., Moul L., Agricola B.A., Metzger M.E., Donahue R.E., Tisdale J.F., Punbar C.E. Introduction of a xenogenic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model // Mol. Ther. — 2000. — Vol.1. — P.533–544.
15. Helg C., Chapuis B., Bolle J.F., Morel P., Salomon D., Roux E., Antonioli V., Jeannet M., Leski M. Renal transplantation without immunosupprension in a host with tolerance induced by allogeneic bone marrow transplantation // Transplantation – 1994. — Vol.58. — P.1420–1422.
16. Kook H., Goldman F., Padley D., Giller R., Rumelhart S., Holida M., Lee N., Peters C., Comito M., Yuling D., Trigg M. Reconstruction of the immune system after unrelated or partially matched Tcell depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery // Blood. — 1996. — Vol.88. — P.1089–1097.
17. Krampera M., Glennie S., Dison J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naпve and memory antigen–specific T–cells to their cognate peptide // Blood. — 2003. — Vol.101. — P.3623–3729.
18. Le Blan K., Rasmusson I., Gotherstrom C., Zetlerberg E., Ringen O. Mesenchimal stem cells inhibit the expression of CD25 (inter 2 receptor. and CD38 on phitohaemagglutinin–activated lymphocytes // Scand J Immunol. — 2004. — Vol.60. — P.307–315.
19. Majumdar M.K., Keane–Moore M., Buyane D., Hardy W.B., Moorman M.A., Mc Intosh K.R., Mosca I.D. Characterrization and Functionality of Cell Surface Molecules on Human Mesenchymal Stem Cells // J.Biomed Sci. — 2003. — Vol.10. — P.228–241.
20. Mathew J.M., Garcia–Morales R.O., Carreno M., Jin I., Tuller L., Blomberger B., Cirocco R., Burke G.W., Ciancio G., Ricordi C., Esquenazi V., Tsakis A., Miller J. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation // Transpl. Immunol. — 2003. — Vol.11. — P.307–321.
21. Nachbaur D., Kropshofer G., Heitger A., Latzer K., Glassl H., Ludescher C., Nussbaumer W., Niederwieser D. Phenotypic and functional lymphocytes recovery after CD34+ enriched versus non–T cell–depleted autologous peripheral blood stem cell transplantation // J. Hematother Stem Cell Res. — 2000. — Vol. 9. — P.727–736.
22. Potian J.A., Aviv H., Ponzio N.M., Harrison J.S., Rameshwar P. Veto–like activity of mesenhimal stem cells: functional discrimination between cellular responses to allogens and recall antigens // J. Immunol.2003. — Vol. 171. — P.3426–3434.
23. Prockop D.J. Futher proof of the plasticity of adult stem cells and their role in tissue repair // The journal of Cell Biology. — 2003. — Vol. 160. — P.807–809.
24. Prockop D.J. Marrow stromal cells as stem cells for non–hemopoietic tissues // Science. — 1997. — Vol.276. — P.71–74.
25. Rasmusson I., Ringden O., Sundberg B., Berit L., Le Blane K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells // Transplantation. — 2003. — Vol.76. — P.1208–1213.
26. Ringden O., Labopin M., Bacigalupo A., Arcese W., Schefer U.W., Willemze R., Koc H., Bunjes B., Gluckman E., Rocha V., Schattenberg A., Frassoni F. Transplantation of Periferal Blood Stem Cells as compared with Bone Marrow from HLAidentical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia // Journal of Clinical Oncology. — 2002. — Vol. 20. — P.4655–4664.
27. Roux E., Dumont–Girard F., Starobinski M., Siegrist C.A., Helg C., Chapuis B., Roosnek E. Recovery of immune reactivity after T–cell –depleted allogeneic bone marrow transplantation depends on thymic activity // Blood. — 2000. — Vol.96. — P.2299–2303.
28. Sayegh M.H., Fine N.A., Smith J.L., Rennke H.G., Milford E.L., Tilney N.L. Immunologic tolerance to renal allografts after bone marrow transplants from the same donor // Ann. Intern. Med.– 1991. — Vol.114. — P.954–955.
29. Schiller G., Vescio R., Freites C., Spitzer G., Sahabi F., Lee M., Wu C.H., Cao J., Lee J.C., Hong C.H. Transplantation of CD34+ peripheral blood progenitor cells after high–dose chemotherapy for patients with advanced multiple myeloma // Blood. — 1995. — Vol. 86. — P.390–397.
30. Shizuru I.A., Weissman I.L., Kernoff R., Masek M., Scheffold Y.C. Purified hematopoietic stem cells grafts induce tolerance to alloantigens and can mediate positive and negative T–cell selection // Proc.Nat.Acad. Sci .USA. — 2000. — Vol.97. — P.9555–9560.
31. Simpson E. Immunotherapy and gene Therapy // Drugs. — 2004. — Vol.7. — P.105–108.
32. Sorof J.M., Kooper M.A., Portale A.A., Potter D., De Santes K., Cowan M. Renal transplantation without chronic immunosuppression after T cell–depleted, HLA–mismatched bone marrow transplantation // Transplantation. — 1995. — Vol. 59 – P.1633–1635.
33. Talvensaari K., Clave E., Douay C., Rabian C., Garderet L., Bussson M., Garnier F., Douek D., Gluckman E., Charron D., Toubert A. A broad T–cell repertoire diversity and an efficient thymic function indicate a favorable long–term immune reconstitution after cord blood stem cells transplantation // Blood. — 2002. — Vol.99 – P.1458–1464.
34. Thompson B.G., Robertson K.A., Gowan D., Heilman D., Broxmeyer H.E., Emanuel D., Kotylo P., Brahmi Z., Smith F.O. Analysis of engraftment, graftversus host disease, and immune recovery following unrelated donor cord blood transplabtation // Blood. — 2000. — Vol.96. — P.2703–2011.
35. Tse W., Pendleton J.D., Beyer V.M., Egalca M.C., Guinan E.C. Suppression of allogenic T–cell proliferation by human marrow stromal cells: implications in transplantation // Transplantation. — 2003. — Vol.75. — P.389–397.
36. Trivedi H.L., Vanicar A.V., Vakil J.M., Shah V.R., Modi P.R., Trivedy V.B. A strategy to achive donor–specific hyporesponsiveness in cadaver renal allograft recipients by donor haematopoetic stem cell transplantation into the thymus and periphery // Nephrol. Dial. Transplant. — 2004. — Vol.19. — P.2374–2377.
37. Urbano–Ispizua A., Garcia–Conde J., Brunet S., Hemander F., Sank Y., Petit J., Bargay J., Figuera A., Rovira M., Solano C., Ojeda E., de la Rubia J., Rozman C. High incidence chronic graft versus host disease after allogenic peripheral blood progenitor cell transplantation // Haematologica. — 1997. — Vol. 82. — P.683–689.
38. Wu C.J., Chillemi F., Alyea E.P., Orsini E., Neuberg D., Soiffer R.J., Ritz J. Recostitution of Tcell repertoire diversity following T–cell depleted allogeneic bone marrow transplantation is related to hematopoietic himerism // Blood. — 2000. — Vol.95. — P.352–359.
Review
For citations:
Lyashenko V.A., Goldshtein D.V., Rzhaninova A.A. THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY. Medical Immunology (Russia). 2005;7(5-6):489-494. (In Russ.) https://doi.org/10.15789/1563-0625-2005-5-6-489-494
Views:
721
Email this article 